NIP
GOSS icon

Nicholas Investment Partners’s Gossamer Bio GOSS Stock Holding History

Nicholas Investment Partners’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-469,317
Closed -$5.62M – 184
2022
Q3 		$5.62M Buy
+469,317
New +$5.83M 0.52% 68
2019
Q3 		– Sell
-143,342
Closed -$3.18M – 207
2019
Q2 		$3.18M Sell
143,342
-607
-0.4% -$11.6K 0.29% 120
2019
Q1 		$3.12M Buy
+143,949
New +$3M 0.28% 123

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nicholas Investment Partners's GOSS Position: Q4 2022 in Review

Nicholas Investment Partners sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 469,317 shares — an estimated $5.62M sold.

Nicholas Investment Partners first reported a position in GOSS in Q1 2019 and held it in 3 quarters. The position peaked at $5.62M in Q3 2022. 120 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Nicholas Investment Partners reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Nicholas Investment Partners sold 469,317 Gossamer Bio shares in Q4 2022, an estimated $5.62M.
  • Nicholas Investment Partners first reported a position in Gossamer Bio in Q1 2019 and held it in 3 quarters.
  • Nicholas Investment Partners's Gossamer Bio position peaked at $5.62M in Q3 2022.
  • 120 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Nicholas Investment Partners's 13F filing for Q4 2022, filed 10 Feb 2023.